Alnylam Competitors and Similar CompaniesClear all
CureVac's competitors and similar companies include Regulus Therapeutics.
 Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs. | ||
Founding Date | Founding Date 2000 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations San Diego, US HQ |
Employees | Employees 999 | Employees 2462% decrease |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 105.4 m |
Financial | ||
Net income | Net income (€260.2m) (FY, 2023) | Net income ($30m) (FY, 2023) |
Operating ⚠ | ||
Patents Issued | Patents Issued 233 (May, 2020) | Patents Issued 300 (FY, 2016) |
Funding | ||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 10m |
For sources of this data, please see the company profile
View Company Profiles
Regulus Therapeutics
HQ
San Diego, US
Employees
24
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
View company